Renal fibrosis
diseaseOn this page
Summary
Renal fibrosis (MONDO:0000494) is a disease and 4 clinical trials. A subtype of glomerulosclerosis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).
At a glance
- Clinical trials: 4
Clinical features
No curated clinical features (Orphanet) for this disease.
Identifiers
Disease identifiers
| Field | Value |
|---|---|
| Canonical name | renal fibrosis |
| Mondo ID | MONDO:0000494 |
| EFO | EFO:1001517 |
| DOID | DOID:0050855 |
| SNOMED CT | 197660000 |
| UMLS | C0151650 |
| MedGen | 508798 |
| Is cancer (heuristic) | no |
Disease family
This is a subtype of glomerulosclerosis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.
Classification path: disease › human disease › disease by body system or component › urinary system disorder › kidney disorder › glomerular disorder › glomerulosclerosis › renal fibrosis
Related subtypes (1): focal segmental glomerulosclerosis
Genetics & variants
GWAS landscape
No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.
Variant details and genetic-evidence tiers
No tiered GWAS variants or ClinVar records for this disease.
Genes & proteins
No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).
Function
No pathway enrichment — requires an associated-gene cohort.
Therapeutics
No druggable-target or therapeutic data for this disease’s cohort.
Clinical trials & evidence
Clinical trials
Clinical trials: 4.
Phase distribution (across all retrieved trials)
| Phase | Trials |
|---|---|
| Not specified | 4 |
Top trials by phase / activity
| NCT | Phase | Status | Title |
|---|---|---|---|
| NCT06210555 | Not specified | RECRUITING | Multiparametric MRI in a Prospective Cohort of Living Kidney Donors, Recipients, and Healthy Controls: Correlations With Markers of Renal Function, Fibrosis and Ageing |
| NCT06563765 | Not specified | ENROLLING_BY_INVITATION | FAP-targeting PET/CT for Noninvasive Monitoring of Renal Fibrosis |
| NCT01613625 | Not specified | COMPLETED | Interest Of Renal Elastography In Children As A Diagnostic Tool Of Renal Fibrosis: Confrontation To Histological Features Of Renal Biopsies |
| NCT03870542 | Not specified | UNKNOWN | Multicenter, Prospective Study for Urinary Exosomal Biomarkers of Kidney Allograft Tubulointerstitial Fibrosis |
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.